Evaluating Efficacy Outcomes in Pediatric Multiple Sclerosis Patients While Using Avonex or Plegridy via USNPMSC Registry.

While there is an increasing trend toward upfront higher efficacy disease-modifying therapies at diagnosis of pediatric multiple sclerosis for improved outcomes, injectables are at times still utilized in the pediatric population, and in unique situations these may be preferred by clinicians and/or families due to other comorbidities.

also in 63,971 other papers